Acer Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage of Acer Therapeutics Inc was prepared by All Street Sevva using leading NLP. This Disclosure score covers seventeen UN SDGs including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Life below Water'. Alternative companies in the rating peer group for Acer Therapeutics Inc are shownin the table.
Acer Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Acer Therapeutics Inc | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Acer Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Acer Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Acer Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Acer Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Acer Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Acer Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Acer Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Acer Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Acer Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Acer Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Acer Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Acer Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Acer Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Acer Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Acer Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Acer Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Acer Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Acer Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.